Skip to content

ELTX - Elicio Therapeutics, Inc. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchE

Elicio Therapeutics Inc.

ELTX · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

E

ELTXElicio Therapeutics Inc.

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $16.00
52-wk low: $2.66
Prev close: $10.26
Mkt cap: $82.3M
Beta: 1.88
P/B: 10.3x

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$9.8M

BA
Balyasny
Dmitry Balyasny · Q1 2026 13F
$2.6M
position
JS
Jim Simons
Q1 2026 13F

Earnings

Reported Aug 6, 2026

Earnings came in 18.9% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $82M

Valuation

P/B10.30

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: ELTX
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $82.26M
Beta: 1.88

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

Profit margin

+0.0%

Op margin

+0.0%

ROE

-775.0%

$1.3M

position

MI

Millennium

Israel Englander · Q1 2026 13F

$992K

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for ELTX

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.43+18.9%

-$0.53 expected

Next report

What the street expects next

-775.0%

ROA-77.9%

Growth

Beta1.88